vs
indie Semiconductor, Inc.（INDI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是indie Semiconductor, Inc.的1.2倍（$69.8M vs $58.0M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -53.8%，领先437.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.3%）
indie Semiconductor是一家无晶圆厂半导体企业，专注于设计高性能混合信号及嵌入式片上系统解决方案，核心面向汽车领域，产品覆盖高级驾驶辅助、车载信息娱乐、车联网及电动汽车场景，服务全球汽车整车厂商及一级供应商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
INDI vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$58.0M
营收增速更快
RIGL
高出21.2%
-0.0%
净利率更高
RIGL
高出437.9%
-53.8%
两年增速更快
RIGL
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.0M | $69.8M |
| 净利润 | $-31.2M | $268.1M |
| 毛利率 | 37.3% | 91.5% |
| 营业利润率 | -58.5% | 33.2% |
| 净利率 | -53.8% | 384.0% |
| 营收同比 | -0.0% | 21.2% |
| 净利润同比 | 9.1% | 1769.2% |
| 每股收益（稀释后） | $-0.16 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDIRIGL
| Q4 25 | $58.0M | $69.8M | ||
| Q3 25 | $53.7M | $69.5M | ||
| Q2 25 | $51.6M | $101.7M | ||
| Q1 25 | $54.1M | $53.3M | ||
| Q4 24 | $58.0M | $57.6M | ||
| Q3 24 | $54.0M | $55.3M | ||
| Q2 24 | $52.4M | $36.8M | ||
| Q1 24 | $52.4M | $29.5M |
净利润INDIRIGL
| Q4 25 | $-31.2M | $268.1M | ||
| Q3 25 | $-38.3M | $27.9M | ||
| Q2 25 | $-39.0M | $59.6M | ||
| Q1 25 | $-34.5M | $11.4M | ||
| Q4 24 | $-34.4M | $14.3M | ||
| Q3 24 | $-49.7M | $12.4M | ||
| Q2 24 | $-19.2M | $-1.0M | ||
| Q1 24 | $-31.2M | $-8.2M |
毛利率INDIRIGL
| Q4 25 | 37.3% | 91.5% | ||
| Q3 25 | 40.1% | 93.2% | ||
| Q2 25 | 40.6% | 95.6% | ||
| Q1 25 | 41.7% | 91.7% | ||
| Q4 24 | 42.6% | 89.9% | ||
| Q3 24 | 39.3% | 85.5% | ||
| Q2 24 | 42.2% | 92.4% | ||
| Q1 24 | 42.5% | 93.1% |
营业利润率INDIRIGL
| Q4 25 | -58.5% | 33.2% | ||
| Q3 25 | -71.4% | 40.9% | ||
| Q2 25 | -83.3% | 60.1% | ||
| Q1 25 | -72.0% | 23.9% | ||
| Q4 24 | -58.4% | 28.9% | ||
| Q3 24 | -92.5% | 25.4% | ||
| Q2 24 | -70.0% | 1.2% | ||
| Q1 24 | -94.8% | -23.6% |
净利率INDIRIGL
| Q4 25 | -53.8% | 384.0% | ||
| Q3 25 | -71.3% | 40.2% | ||
| Q2 25 | -75.6% | 58.6% | ||
| Q1 25 | -63.9% | 21.5% | ||
| Q4 24 | -59.2% | 24.9% | ||
| Q3 24 | -92.1% | 22.5% | ||
| Q2 24 | -36.6% | -2.8% | ||
| Q1 24 | -59.6% | -27.9% |
每股收益（稀释后）INDIRIGL
| Q4 25 | $-0.16 | $14.11 | ||
| Q3 25 | $-0.19 | $1.46 | ||
| Q2 25 | $-0.20 | $3.28 | ||
| Q1 25 | $-0.18 | $0.63 | ||
| Q4 24 | $-0.18 | $0.82 | ||
| Q3 24 | $-0.28 | $0.70 | ||
| Q2 24 | $-0.11 | $-0.06 | ||
| Q1 24 | $-0.19 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.5M | $155.0M |
| 总债务越低越好 | $353.4M | $52.5M |
| 股东权益账面价值 | $358.0M | $391.5M |
| 总资产 | $840.8M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.99× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资INDIRIGL
| Q4 25 | $145.5M | $155.0M | ||
| Q3 25 | $160.9M | $137.1M | ||
| Q2 25 | $192.6M | $108.4M | ||
| Q1 25 | $236.6M | $77.1M | ||
| Q4 24 | $274.2M | $77.3M | ||
| Q3 24 | $96.9M | $61.1M | ||
| Q2 24 | $112.3M | $49.1M | ||
| Q1 24 | $138.2M | $49.5M |
总债务INDIRIGL
| Q4 25 | $353.4M | $52.5M | ||
| Q3 25 | $353.5M | $60.0M | ||
| Q2 25 | $352.5M | $60.0M | ||
| Q1 25 | $379.0M | $60.0M | ||
| Q4 24 | $381.3M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益INDIRIGL
| Q4 25 | $358.0M | $391.5M | ||
| Q3 25 | $369.2M | $117.6M | ||
| Q2 25 | $390.4M | $81.9M | ||
| Q1 25 | $405.6M | $18.6M | ||
| Q4 24 | $417.9M | $3.3M | ||
| Q3 24 | $458.6M | $-14.6M | ||
| Q2 24 | $470.7M | $-29.9M | ||
| Q1 24 | $432.9M | $-31.7M |
总资产INDIRIGL
| Q4 25 | $840.8M | $513.6M | ||
| Q3 25 | $855.1M | $242.5M | ||
| Q2 25 | $867.6M | $206.7M | ||
| Q1 25 | $909.0M | $176.0M | ||
| Q4 24 | $941.4M | $164.0M | ||
| Q3 24 | $797.5M | $139.4M | ||
| Q2 24 | $797.3M | $128.4M | ||
| Q1 24 | $803.6M | $126.5M |
负债/权益比INDIRIGL
| Q4 25 | 0.99× | 0.13× | ||
| Q3 25 | 0.96× | 0.51× | ||
| Q2 25 | 0.90× | 0.73× | ||
| Q1 25 | 0.93× | 3.23× | ||
| Q4 24 | 0.91× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-16.1M | — |
| 自由现金流率自由现金流/营收 | -27.8% | — |
| 资本支出强度资本支出/营收 | 3.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-71.4M | — |
8季度趋势，按日历期对齐
经营现金流INDIRIGL
| Q4 25 | $-14.4M | $22.0M | ||
| Q3 25 | $-6.2M | $24.0M | ||
| Q2 25 | $-7.6M | $30.5M | ||
| Q1 25 | $-29.0M | $-893.0K | ||
| Q4 24 | $-6.7M | $14.5M | ||
| Q3 24 | $-22.8M | $21.7M | ||
| Q2 24 | $-19.7M | $302.0K | ||
| Q1 24 | $-9.3M | $-5.0M |
自由现金流INDIRIGL
| Q4 25 | $-16.1M | — | ||
| Q3 25 | $-10.3M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-31.4M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-29.3M | — | ||
| Q2 24 | $-23.4M | — | ||
| Q1 24 | $-11.7M | — |
自由现金流率INDIRIGL
| Q4 25 | -27.8% | — | ||
| Q3 25 | -19.2% | — | ||
| Q2 25 | -26.4% | — | ||
| Q1 25 | -58.0% | — | ||
| Q4 24 | -14.8% | — | ||
| Q3 24 | -54.3% | — | ||
| Q2 24 | -44.7% | — | ||
| Q1 24 | -22.3% | — |
资本支出强度INDIRIGL
| Q4 25 | 3.0% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 4.4% | — |
现金转化率INDIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
RIGL
暂无分部数据
